Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 6e-05 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |